Drugs / Calcio levofolinate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03387592 Comparator | Mar 2017 → Feb 2022 | neuroendocrine carcinoma | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Terminated | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcio levofolinate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03387592 ↗ |
| Route | Intravenous | “given as a 2h i.v. infusion” NCT03387592 ↗ |